Machine learning to predict post-therapy dosimetry for 177Lu-PSMA I&T treatment

被引：0
|
作者：
Shi, K. [1 ]
Xue, S. [1 ]
Gafita, A. [2 ]
Dong, C. [2 ]
Zhao, Y. [2 ]
Tetteh, G. [2 ]
Menze, B. H. [2 ]
Afshar-Oromieh, A. [1 ]
Eiber, M. [2 ]
Rominger, A. [1 ]
机构：
[1] Univ Bern, Bern, Switzerland
[2] Tech Univ Munich, Munich, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-441
引用
收藏
页码：S170 / S170
页数：1
相关论文
共 50 条
  • [41] Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [177Lu]Lu-PSMA I&T
    Hartrampf, Philipp E.
    Weinzierl, Franz-Xaver
    Serfling, Sebastian E.
    Pomper, Martin G.
    Rowe, Steven P.
    Higuchi, Takahiro
    Seitz, Anna Katharina
    Kuebler, Hubert
    Buck, Andreas K.
    Werner, Rudolf A.
    CANCERS, 2022, 14 (03)
  • [42] Comparison of absorbed dose to kidneys using quantitative SPECT/CT and whole body planar images for 177Lu-PSMA I&T in prostate cancer therapy
    Ghodoosi, E. Karimi
    D'Alessandria, C.
    Eiber, M.
    Li, W.
    Navab, N.
    Ziegler, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S112 - S113
  • [43] The use of molecular volumetric parameters for the evaluation of Lu-177 PSMA I&T therapy response and survival
    Emine Acar
    Özhan Özdoğan
    Ayşegül Aksu
    Erkan Derebek
    Recep Bekiş
    Gamze Çapa Kaya
    Annals of Nuclear Medicine, 2019, 33 : 681 - 688
  • [44] Impact of cross-irradiation on single time-point dosimetry in 177Lu-PSMA therapy
    Vergnaud, L.
    Badel, J.
    Giraudet, A.
    Sarrut, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S804 - S804
  • [45] Patient-specific pharmacokinetics and dosimetry over multiple therapy cycles during 177Lu-based radionuclide therapy: a study for 177Lu-DOTATATE and 177Lu-PSMA
    Gosewisch, A.
    Ermoschkin, L.
    Ilhan, H.
    Todica, A.
    Vamacka, L.
    Bartenstein, P.
    Boening, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S270 - S271
  • [46] Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T
    Karimzadeh, Amir
    Soeiro, Paula
    Feuerecker, Benedikt
    Hecker, Charlotte-Sophie
    Knorr, Karina
    Heck, Matthias M.
    Tauber, Robert
    Alessandria, Calogero D. '
    Weber, Wolfgang A.
    Eiber, Matthias
    Rauscher, Isabel
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (11) : 1765 - 1771
  • [47] Insights into treatment optimization: Mathematical modeling of tumor growth in 177Lu-PSMA therapy
    Zaid, Nouran
    Bastiaannet, Remco
    Hobbs, Robert
    Sgouros, George
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [48] Evaluation of radiation safety in 177Lu-PSMA therapy and development of outpatient treatment protocol
    Demir, Mustafa
    Abuqbeitah, Mohammad
    Uslu-Besli, Lebriz
    Yildirim, Ozlem
    Yeyin, Nami
    Cavdar, Iffet
    Vatankulu, Betul
    Gunduz, Huseyin
    Kabasakal, Levent
    JOURNAL OF RADIOLOGICAL PROTECTION, 2016, 36 (02) : 269 - 278
  • [49] Value of Post-Therapy Quantitative SPECT for Monitoring Response to 177Lu-PSMA-617 Therapy
    Meyer, Catherine
    Yilmaz, Burcak
    Szidonya, Laszlo
    Winters, Celeste
    Mench, Anna
    Mallak, Nadine
    Mittra, Erik
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [50] Radioligand Treatment with [177Lu]Lu-PSMA I&T in the Older Patients - Safety, Efficacy, and Prognostic Factors for Survival
    Weber, Simon
    Seitz, Anna
    Kuebler, Hubert
    Buck, Andreas
    Werner, Rudolf
    Hartrampf, Philipp
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
12345